The Antibody Series 2022
The 2nd edition of The Antibody Series took place at Pavilhão Rosa Mota, an emblematic spot in the heart of Porto. The 2022 scientific agenda was defined by our invited chairman Ton Logtenberg, Founder of Merus N.V. and included special Keynotes and topics on Neurodegenerative Diseases, Artificial Intelligence & Antibodies, Novel Mechanisms of Action and Targeting the Tumor Micro-environment.

Gallery
2022 Speakers

Senior Principal Research Scientist, Head of Systems Immunology, Head of Immune Profiling Center,

Application Science Manager at Carterra

Director in Protein Therapeutics, Group Leader in Biologics Engineering

Associate Vice President of Biotherapeutics at Incyte Corp

Chief Scientific Officer at Alchemab Therapeutics

CSO and Head of Discovery at Denali Therapeutics

Merus NV

Head of Protein Engineering at MiroBio

Head Cancer Immunotherapy Discovery, Roche Innovation Center Zurich, pRED

Albert M. Mattocks (Endowed) Professor in the Departments of Chemical Engineering, Pharmaceutical Sc